Quick Answer
TriSalus Life Sciences, Inc. reported Total Revenue of $45.15 million for fiscal year 2025.
TriSalus Life Sciences, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $45.15M | +53.4% |
| 2024 | $29.43M | +59.0% |
| 2023 | $18.51M | +49.3% |
| 2022 | $12.40M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $11.57M | +57.4% | +3.1% |
| June 30, 2025 | $11.21M | +52.3% | +22.3% |
| March 31, 2025 | $9.17M | +42.0% | +24.7% |
| September 30, 2024 | $7.35M | +41.5% | -0.2% |
| June 30, 2024 | $7.36M | +59.7% | +14.0% |
| March 31, 2024 | $6.46M | +116.4% | +24.3% |
| September 30, 2023 | $5.19M | +32.4% | +12.6% |
| June 30, 2023 | $4.61M | — | +54.6% |
- TriSalus Life Sciences, Inc. showed an increase of +53.4% in Total Revenue compared to the prior fiscal year.
- Over the 2022–2025 period, TriSalus Life Sciences, Inc.’s total revenue has grown by 264.2% (from $12.40 million to $45.15 million).
- The most recent figure is from TriSalus Life Sciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: